SLC29A2 and cancer: The clinical importance of ENT2 is becoming more recognized; however, the role of hENT2 as a biomarker in the management of the different cancer types requires further research to specify whether ENT2 gene may play a role in inducing the biological process to suppress the cancer cells and/or improve the possibilities of cancer therapeutic strategies.